HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A response to "Comment on 'A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis'".

AuthorsRobert J Pariser
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 70 Issue 5 Pg. 951 (May 2014) ISSN: 1097-6787 [Electronic] United States
PMID24742842 (Publication Type: Letter, Comment)
Chemical References
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
Topics
  • Anti-Inflammatory Agents (administration & dosage)
  • Antibodies, Monoclonal, Humanized (administration & dosage)
  • Female
  • Humans
  • Male
  • Sarcoidosis (drug therapy)
  • Skin Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: